269 YouTube and gestational diabetes: what are patients watching?

Abstract

50.1%]), obstetric (n¼36 [36.4%; 95% CI, 26.9-45.8%]), and fetal genetic/structural abnormalities (n¼28 [28.3%; 95% CI,). Most frequently performed testing included maternal antibody screen (98; 99.0%), syphilis screening (91; 91.9%), and placental histology (94; 94.9%) while less than half of cases underwent PME (45; 45.5%). While antibody screen and syphilis testing infrequently yielded positive results (n¼4, 4.1%; and 0), placental histologic examinations (n¼72, 76.6%) and PME (n¼36, 80%) contributed significantly to the assignment of possible or probable cause of death. Of women with SB and no PME (n¼54), probable cause of SB was found in 61% (n¼33 [95% CI, 48.1-74.1%]) and probable or possible cause identified in 89% (n¼48 [95% CI, 80.5-97.3%]). Over one-third of SB occurred between 20 to 24 weeks gestation (n¼38; 38.4%). Of SB at gestations less than 24 weeks, a greater proportion of SB occurred intrapartum than those at 24 weeks or later (34.1%vs12.7%; 95% CI, 4.8-37.9%, P¼0.011). CONCLUSION: The INCODE algorithm identified a possible or probable cause of death in the majority of SB, comparing favorably to the results reported by SCRN, confirming its utility in a clinical setting where PME is not routinely performed.